Overview
- Description
A novel combination treatment effective against all multidrug-resistant pathogens deemed as a critical priority by the WHO.
- Website
- Country
- France
- Sector
- Health Biotechnology
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.